From Product to Platform, Gemina Provides a Technology Roadmap

VANCOUVER, BC / ACCESSWIRE / February 15, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the “Company” or “Gemina“) is pleased to provide the following strategic overview and share an outlook for 2022 and beyond. Gemina’s Chemistry Platform The Company is powered by Gemina’s breakthrough chemistry, which underpins the development of next generation diagnostics and biosensors for […]

Read More